Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
What is new in 2023 for tax and asset protection planning
As we are in early 2023, we plan to use this column to provide a high-level update on new developments in tax and asset protection planning, and hope these updates prompt some physicians to look into these areas early in the year.
The Latest News and Notes, live from Hawaiian Eye
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news stories, live from Hawaiian Eye.
Log in or Sign up for Free to view tailored content for your specialty!
BLOG: Introduction to taxation of sale proceeds: S corporation
Our next post in this series addresses the taxation of sale proceeds if a target practice is classified as an S corporation.
Wearing multiple hats: How to multitask and balance career paths outside of clinical practice
Dagny Zhu, MD, Cathleen M. McCabe, MD, and Laura M. Periman, MD, talk with Cynthia A. Matossian, MD, FACS, about the multitude of career pathways in ophthalmology and balancing career with family.
Affordable Care Act enrollment hits record numbers
A record number of Americans — 16.3 million — signed up for health insurance through Affordable Care Act Marketplaces in 2023, the Biden-Harris administration announced Wednesday.
Pre-residency research, publications may be predictive of future academic career
Pre-residency publication history is associated with later publications in journals with a high impact factor and first authorships and may predict a future academic career, according to a study.
Amazon launches discount prescription drug service
Amazon has further expanded its reach into health care with a new discount prescription drug program.
The Latest News and Notes, plus Conversation with Allergan alumni
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Gavin Herbert, Tom Burns, Andy Corley and Tom Mitro to discuss their days at Allergan and what they have learned from their experiences.
Overall risk for hydroxychloroquine retinopathy low, increases with higher doses
The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was low but progressively increased with higher doses, according to researchers.
A thorough, efficient practice depends on preparation and training
KOLOA, Hawaii — Glaucoma practices can take steps to increase efficiency without compromising patient satisfaction, according to a speaker here.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read